Iran Opens Cold Plasma Wound Treatment Clinic in Firouzabad | AEOI

February 16, 2026 – Iran has expanded its capacity for advanced wound care with the inauguration of its 16th specialized clinic utilizing cold plasma technology. The new facility, located at Hazrat Qaem (AS) Hospital in Firouzabad County, Fars Province, represents a growing investment in innovative medical treatments within the country.

Cold Plasma Technology: A Modern Approach to Wound Healing

Cold plasma, often referred to as non-thermal plasma, is an emerging technology in wound care. Unlike traditional methods, it doesn’t rely on heat, making it suitable for a wider range of wounds and potentially minimizing damage to surrounding healthy tissue. The technology works by generating ionized gases that contain reactive species – molecules and atoms with unpaired electrons – which have antimicrobial properties and can stimulate cellular processes crucial for wound healing.

These reactive species contribute to several beneficial effects. They can effectively kill bacteria, including antibiotic-resistant strains, reducing the risk of infection. Cold plasma can promote angiogenesis, the formation of new blood vessels, which is essential for delivering oxygen and nutrients to the wound site. It also encourages fibroblast activity, leading to increased collagen production and improved tissue regeneration.

Iran’s Expanding Network of Cold Plasma Clinics

The opening of the Firouzabad clinic marks a significant step in Iran’s commitment to integrating cold plasma technology into its healthcare system. The inauguration was attended by Mohammad Eslami, Head of the Atomic Energy Organization of Iran (AEOI), and Hossein-Ali Amiri, the Governor of Fars Province, highlighting the collaborative effort between medical institutions and governmental bodies.

According to reports, the AEOI has played a key role in supplying and launching the equipment used at the clinic, indicating a strategic focus on leveraging the organization’s expertise in related technologies. This collaboration suggests a broader initiative to develop and implement advanced medical solutions within Iran. The establishment of 16 specialized clinics demonstrates a deliberate effort to make this technology more accessible to patients across the country.

Applications and Potential Benefits of Cold Plasma Wound Care

Cold plasma therapy is showing promise in treating a variety of chronic and acute wounds that have been difficult to heal with conventional methods. These include:

• Diabetic Foot Ulcers: A common and serious complication of diabetes, these ulcers often resist traditional treatments. Cold plasma’s antimicrobial properties and ability to stimulate tissue regeneration offer a potential solution.
• Pressure Ulcers (Bedsores): These develop in individuals with limited mobility and can be prone to infection.
• Venous Leg Ulcers: Caused by poor blood circulation, these ulcers can be chronic and debilitating.
• Surgical Wounds: Cold plasma can potentially accelerate healing and reduce the risk of infection in post-surgical wounds.
• Burn Wounds: The technology’s antimicrobial properties can be particularly beneficial in preventing infection in burn injuries.

While research is ongoing, early studies suggest that cold plasma therapy can significantly reduce wound healing time, decrease pain, and improve overall patient outcomes. The technology is generally considered safe, with minimal side effects reported in clinical trials. However, it’s important to note that cold plasma therapy is not a one-size-fits-all solution and may not be appropriate for all types of wounds or patients.

The Role of the AEOI and Future Prospects

The involvement of the AEOI in the development and implementation of cold plasma technology raises interesting questions about the intersection of nuclear science and medical innovation. The AEOI’s expertise in plasma physics, a core component of nuclear technology, appears to be directly applicable to the generation and control of cold plasma for medical applications.

The continued expansion of cold plasma clinics in Iran suggests a long-term commitment to this technology. Further research and development are likely to focus on optimizing treatment protocols, expanding the range of applications, and improving the accessibility of this innovative wound care solution. The success of these clinics could potentially serve as a model for other countries seeking to incorporate advanced technologies into their healthcare systems.

As cold plasma technology continues to evolve, it holds the potential to revolutionize wound care, offering a new hope for patients suffering from chronic and difficult-to-heal wounds.